
Spring 2003
Michael B. Fauntleroy ,Food and Drug Administration, Center for Biologics Evaluation and Research
Alan Riga(a,c) Rui MacĂȘdo(b),Ken Alexander(c) and Gene C. Pan(d)a. Department of Chemistry, Cleveland State University
Teresa Head and Jim Rydzak, GlaxoSmithKline
Sandy Weinberg, Ph.D., Linnaeus Chair of Biomedical Entrepreneurship, Muhlenberg College
Harry G. Brittain, Ph.D. and Gregory Amidon, Ph.D.,Center for Pharmaceutical Physics and Pharmacia Corporation
Brian R. Rohrs, Ph.D.,Pharmacia Corporation
Paul Stinavage, Ph.D.,Food and Drug Administration, Center for Drug Evaluation and Research
Gary E. Ritchie, Principal Scientist, Saeed Hashemi, Scientist,Purdue Pharma LP, International Research & Development (U.S.)
William Supplee , McNeil Consumer Healthcare
Richard A. Storey, Ph.D., Robert Docherty, Ph.D., & Paul D. Higginson,Pharmaceutical Sciences, Pfizer Global R&D, Sandwich, Kent, UK
Paul Matejtschuk(1*), Michelle Andersen(1), Roland Fleck(2), Colin Longstaff(3), Peter Phillips(1), Standards(1), Cell Biology & Imaging(2) and Haematology(3) Divisions, National Institute for Biological Standards & Control
Navnit Shah, Ph.D., Wantanee Phuapradit, Ph.D. and Hashim Ahmed, Ph.D., Hoffmann-La Roche Inc.
Ronald W. Miller, Ph.D.,Bristol-Myers Squibb Global Pharmaceutical Technology & Development
Lisa K. Minor, Ph.D.,Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Richard L. Friedman & Stephen C. Mahoney, Food and Drug Administration, Center for Drug Evaluation and Research